Jasleen Minhas is a Respiratory physician affiliated with Penn Center for AIDS Research. OpenAlex indexes 64 publications with 731 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Spruce Street
3 Ravdin Bldg Ste F
Philadelphia, PA 191044206
Telephone
215-662-3202Provider last certified this registry record 18 Feb 2022.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%beta2-Adrenergic Agonist100%Albuterol Sulfate Hfa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Physical activity phenotypes and their association with traditional outcomes in pulmonary arterial hypertension
University of Pennsylvania
FY2026$192,597K23HL169930 - Physical activity phenotypes and their association with traditional outcomes in pulmonary arterial hypertension
University of Pennsylvania
FY2025$189,931K23HL169930 - Physical activity phenotypes and their association with traditional outcomes in pulmonary arterial hypertension
University of Pennsylvania
FY2024$192,231K23HL169930
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Frailty in Pulmonary Arterial Hypertension: A Cohort Study
Annals of the American Thoracic Society
2026 - Ambient Air Pollution Exposure and Mortality in the Pulmonary Hypertension Association Registry
Annals of the American Thoracic Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Charu Aggarwal, MD, MPH
Penn Center for AIDS Research
Janos Tanyi, MD
Penn Center for AIDS Research
Daniel Landsburg, MD
Penn Center for AIDS Research
Bryson Katona, MD, PhD
Penn Center for AIDS Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”